Unidade Local de Saúde de Gaia e Espinho
Vila Nova de Gaia, Portugal
We welcome Unidade Local de Saúde de Gaia e Espinho to the IASIOS community. This enrolment underscores their commitment to advancing interventional oncology and enhancing patient care. We are pleased to see the IASIOS community expanding in Portugal and are excited to support their journey towards achieving excellence in the field.
CHU de São João
Porto, Portugal
IASIOS is proud to welcome CHU de São João as a new Enrolled Centre.
Joining IASIOS reflects the centre’s strong commitment to advancing interventional oncology through robust quality assurance, patient-focused care, and alignment with internationally recognised standards.
As part of the IASIOS community, CHU de São João becomes part of a global network of institutions dedicated to enhancing cancer care through collaboration, continuous improvement, and the sharing of best practices.
We are pleased to accompany the team at CHU de São João as they embark on their journey toward IASIOS accreditation.
Cleveland Clinic Abu Dhabi
Abu Dhabi, United Arab Emirates
Cleveland Clinic Abu Dhabi became the first centre in the United Arab Emirates to receive IASIOS accreditation! We commend Dr. Fadi Youness and the team for their dedication to providing the highest-quality cancer care through excellence in interventional oncology.
Members of the IASIOS Steering Board and Council
Mallinckrodt Institute of Radiology
St. Louis, Missouri, USA
We are delighted to highlight a notable accreditation achievement: the Mallinckrodt Institute of Radiology has been officially designated as an IASIOS Accredited Centre.
IASIOS accreditation signifies a dedication to robust clinical governance, adherence to the best available evidence, and an ongoing drive for excellence and innovation within interventional oncology. It also emphasises the increasing importance of image-guided, minimally invasive techniques as a core component of modern oncologic treatment strategies.
Our sincere congratulations to the entire interventional radiology team at the Mallinckrodt Institute of Radiology for this outstanding accomplishment, which positions them as a leading example of excellence in interventional oncology.
St. Jude Children’s Research Hospital
Memphis, USA
The IASIOS community welcomes St. Jude Children’s Research Hospital, the first paediatric facility to enrol in our accreditation process! We celebrate their commitment to best practices and exceptional patient care in interventional oncology.
National Institutes of Health (NIH)
Bethesda, USA
We are thrilled to welcome the National Institutes of Health (NIH) to the IASIOS community! This enrolment marks a major milestone, showcasing NIH’s profound dedication to pushing the boundaries of interventional oncology and elevating patient care to new heights. Their entry into IASIOS promises to drive innovation and set new standards in the field.
St. Vincent’s Healthcare Group
Dublin, Ireland
Congratulations to Prof. Colin Cantwell, Prof. David Brody, Dr. Colin O’Rourke, and the St. Vincent’s Healthcare Group team in Ireland for achieving IASIOS accreditation. This milestone reflects their dedication to providing exceptional, high-quality cancer care by the CIRSE Standards of Quality Assurance in Interventional Oncology.
Members of the IASIOS Steering Board and Council
King Fahad Medical City
Riyadh, Saudi Arabia
King Fahad Medical City becomes the first facility in Saudi Arabia to achieve the IASIOS accreditation! Congratulations to the team for their hard work throughout the application process, proving their adherence to the CIRSE Standards of Quality Assurance in Interventional Oncology.
Kantonsspital Graubünden
Graubünden, Switzerland
Kantonsspital Graubünden has proudly become the second facility in Switzerland to achieve IASIOS accreditation. Dr. Patrick Knüsel and the rest of the team have proven their commitment to advancing interventional oncology and offering high-quality cancer care.
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy
IASIOS welcomes Prof. Rosario Francesco Grasso and the entire team at the Fondazione Policlinico Universitario Campus Biomedico as an Enrolled Centre. The IASIOS community in Italy continues to grow, a testament to their dedication to advancing interventional oncology.